Accelerate Diagnostics is an Arizona-based company that offers diagnostic services for antibiotic resistance and hospital acquired infections.
Business Model:
Revenue: $13.3M
Employees: 201-500
Address: 3950 S. Country Club Road
City: Tucson
State: AZ
Zip: 85714
Country: US
Accelerate Diagnostics is an Arizona-based company that offers diagnostic services for antibiotic resistance and hospital acquired infections.
Contact Phone:
+15203653100
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/3/2013
Ticker Symbol:
AXDX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2010 | Venture Round | $275k | 5/2014 | Post-IPO Equity | $0 |
Oracle Jack W. Schuler Living Trust Schuler Family Foundation Oracle Jack W. Schuler Living Trust Schuler Family Foundation |
6/2021 | Grant | $0 |
CARB-X CARB-X |
8/2013 | Venture Round | $20M | 8/2013 | Venture Round | $3.3M | 6/2014 | Post-IPO Equity | $19.5M | 3/2021 | Post-IPO Equity | $32M | 7/2012 | Venture Round | $14.4M | 4/2022 | Post-IPO Equity | $4M | 12/2015 | Post-IPO Equity | $109M | 9/2021 | Post-IPO Debt | $51M | 3/2022 | Post-IPO Equity | $4M | 8/2019 | Post-IPO Equity | $1000k | 8/2022 | Post-IPO Equity | $32.2M | 4/2020 | Debt | $4.8M |
National Bank of Arizona |
6/2021 | Grant | 1 | $578k |
CARB-X CARB-X |
5/2014 | Post-IPO Equity | 3 | $45M |
Oracle Jack W. Schuler Living Trust Schuler Family Foundation Oracle Jack W. Schuler Living Trust Schuler Family Foundation |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|